Sponsor study identifier
interventional
40
1 country
1
Study Start
March 1, 2011
Actual (reported)Primary Completion
March 1, 2021
Actual (reported)Study Completion
March 1, 2021
Actual (reported)The aim is to compare percutaneous transhepatic biliary drainage (PTBD) with primary metal stent implantation (one stage-procedure) with PTBD with secondary metal stent implantation in terms of adverse events.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 1, 2021
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 1, 2011
Actual (reported)March 1, 2021
Actual (reported)March 1, 2021
Actual (reported)August 1, 2021
Actual (reported)August 5, 2021
Actual (reported)Adverse events
All adverse events which have been documented in the medical record were analyzed and classified as mild, moderate, severe or fatal/death according to the AE severity grading system of the American Society of Gastrointestinal Endoscopy (ASGE)
From the intervention until 30 days after
PTBD with primary metal stent implantation is performed in the same session as a one step-procedure
PTBD with secondary metal stent implantation is performed as a two step-procedure with metal stent implantation 3 to 7 days after previous percutaneous transhepatic biliary drainage and insertion of a plastic catheter
A self-expandable metal stent is inserted into the extrahepatic bile duct which is obstructed by malignant disease
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Tertiary referral hospital: Theresienkrankenhaus und St. Hedwig Hospital, Academic
Mannheim, 68165, Germany
Sharaiha RZ, Khan MA, Kamal F, Tyberg A, Tombazzi CR, Ali B, Tombazzi C, Kahaleh M. Efficacy and safety of EUS-guided biliary drainage in comparison with percutaneous biliary drainage when ERCP fails: a systematic review and meta-analysis. Gastrointest Endosc. 2017 May;85(5):904-914. doi: 10.1016/j.gie.2016.12.023. Epub 2017 Jan 4.
Venkatanarasimha N, Damodharan K, Gogna A, Leong S, Too CW, Patel A, Tay KH, Tan BS, Lo R, Irani F. Diagnosis and Management of Complications from Percutaneous Biliary Tract Interventions. Radiographics. 2017 Mar-Apr;37(2):665-680. doi: 10.1148/rg.2017160159.
Daniel Schmitz, MD
Theresienkrankenhaus Mannheim, University of Heidelberg
40 participants (actual enrollment reported by the registry).
First Submitted
August 1, 2021
First Posted
August 5, 2021
Study Start
March 1, 2011
Actual (reported)Contact the study team to confirm eligibility.
Cotton PB, Eisen GM, Aabakken L, Baron TH, Hutter MM, Jacobson BC, Mergener K, Nemcek A Jr, Petersen BT, Petrini JL, Pike IM, Rabeneck L, Romagnuolo J, Vargo JJ. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc. 2010 Mar;71(3):446-54. doi: 10.1016/j.gie.2009.10.027. No abstract available.
Primary Completion
March 1, 2021
Actual (reported)Study Completion
March 1, 2021
Actual (reported)Last Updated
August 12, 2021
Record last verified: 2021-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: